Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tumor biomarkers

Tumor biomarkers are molecules or substances found in blood, tissues, or other bodily fluids that indicate the presence or progression of cancer. They can be proteins, genes, or other indicators linked to tumor activity and help in diagnosing, predicting prognosis, and monitoring treatment responses. Biomarkers are essential for personalizing treatment plans and assessing the effectiveness of therapies. Advancements in biomarker research aim to improve early detection and precision medicine.

Tumor biomarkers